Login

Username or email address

Enter your username or email address.

Password

Enter the password that accompanies your username.

Request new password

Progress in Mind SEA

Topics
Congress Highlights
- EAN 2023
- WPA 2022
- EPA 2022
- APA 2022
- EAN 2022
- WCN 2021
- ECNP 2021
- IHC 2021
- AAN 2021
- AHS 2021
- EPA 2021
- WPA 2021
- CINP 2021
BRAIN MASTER
ASK THE EXPERTS
About

Search

Articles

Tolerability

Schizophrenia 19 Oct, 2023 Read Time: 5 mins

Congress highlights Article

The importance of patient life engagement in schizophrenia

At the 2023 ECNP Congress in Barcelona, Spain (7−10th Oct), two symposia explored the importance of...
Migraine 12 Oct, 2022 Read Time: 4 mins

Satellite symposium Article

A spotlight on time in migraine management

Time lost providing patients with migraine with effective treatment is time lost for the patient’s...
Migraine 15 Sep, 2022 Read Time: 3 mins

Satellite symposium Article

Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world

Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,...
Migraine 13 Sep, 2022 Read Time: 5 mins

Satellite symposium Article

Experts’ perspectives on managing chronic migraine in their own clinical practice

Three experts from different countries provided perspectives on their own clinical practice managing...
Schizophrenia 12 Nov, 2021 Read Time: 3 mins

Satellite symposium

Balancing efficacy and tolerability to personalize treatment choices in schizophrenia

The Precision Medicine Initiative was launched in 2015 in the United States. This approach to disease...
Bipolar 12 Nov, 2021 Read Time: 5 mins

Article

Role of the CINP 2017 Treatment Guidelines for Bipolar Disorder in clinical practice

The CINP 2017 Treatment Guidelines for Bipolar Disorder have been developed from a detailed analysis...
Depression, Schizophrenia 12 Nov, 2021 Read Time: 4 mins

Congress highlights

Why do we need new treatments for major depressive disorder and schizophrenia?

Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as...

Progress in Mind South East Asia

HCP Access Verification Required

To gain access, please provide details to verify you are a healthcare professional.

Register Login

If you are not located in South East Asia click here.

Brought to you by

© 2022 Lundbeck SEA

PROGRESS IN MIND SOUTH EAST ASIA

Disclaimer and privacy statement

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue